Summary
Sanara MedTech Inc. develops, markets, and distributes wound and skin care products to physicians, hospitals, clinics, and post-acute care settings in the United States. It offers CellerateRX Surgical Activated Collagen powder and gel that are used in a range of surgical specialties to help promote patient healing; Biako¯s Antimicrobial Skin and Wound Cleanser, a patented product that disrupts extracellular polymeric substances to eradicate mature biofilm microbes; Biako¯s Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing helps against planktonic microbes, as well as immature and mature biofilms; and Biako¯s Antimicrobial Skin and Wound Irrigation Solution. The company also provides HYCOL Hydrolyzed Collagen Powder and Gel, a medical hydrolysate of Type I bovine collagen for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. In addition, it develops FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; and VIM Amnion Matrix, a single layer sheet of amnion tissue. The company was formerly known as WNDM Medical Inc. and changed its name to Sanara MedTech Inc. in May 2019. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.
History
Sanara MedTech was founded by medical professionals in 2003 to address the issue of lack of access to quality medical equipment for most of India. On founding, Sanara faced multiple challenges to setting up manufacturing and distribution of quality medical technology solutions and services. Over the past ten years, Sanara has established itself as a major player in the Indian healthcare industry. Today, it is one of India’s premier medical technology companies with a reach to over 30 countries.
Mission
Sanara MedTech is committed to making healthcare better and accessible to everyone. We strive to provide the best solutions and services to our customers. Our mission is to enable optimal healthcare access to the global population through innovative, sustainable and quality solutions and services.
Vision
Our vision is to create a world where access to quality healthcare is available to everyone, enabling a better and healthier life.
Key Team
Mr. Callon Nichols (Director of Investor Relations)
Mr. Bill Fitzgerald (Compliance Officer)
Dr. Jane A. Fore (Chief Medical Officer)
Ms. Tricia Matteson (Sr. Director of Marketing)
Ms. Carla Day (Director of Customer & Sales Services)
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D. (Pres of Telehealth Services)
Dr. Rebecca Erin Mcmahon (Pres of R&D)
Recognition and Awards
Sanara MedTech has been consistently recognised for its leadership in the medical technology industry and awarded several prestigious awards such as the Best Company for Healthcare Technology Solutions Award, Best Company for Manufacturing Excellence Award, Best Company for Patient Care Solutions Award etc.
References
United States 